OCT4&SOX2‐specific cytotoxic T lymphocytes plus programmed cell death protein 1 inhibitor presented with synergistic effect on killing lung cancer stem‐like cells in vitro and treating drug‐resistant lung cancer mice in vivo-Reference-Cited by-同舟云学术

OCT4&SOX2‐specific cytotoxic T lymphocytes plus programmed cell death protein 1 inhibitor presented with synergistic effect on killing lung cancer stem‐like cells in vitro and treating drug‐resistant lung cancer mice in vivo

Published:2018-11 Issue:5 Volume:234 Page:6758-6768
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J Cell Physiol

Author:

Zhang Xueyan¹,Hu Fang¹,Li Changhui¹,Zheng Xiaoxuan¹,Zhang Bo¹,Wang Huimin¹,Tao Guangyu¹,Xu Jianlin¹,Zhang Yanwei¹,Han Baohui¹^ORCID

Affiliation:

1. Department of Pulmonary Shanghai Chest Hospital, Shanghai Jiao Tong University Shanghai China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcp.27423

Reference42 articles.

1. Tumor-Specific Cytotoxic T Cells Are Crucial for Efficacy of Immunomodulatory Antibodies in Patients with Lung Cancer

2. B Cells Directly Tolerize CD8+ T Cells

3. Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responsesin vitro

4. The cancer stem-cell signaling network and resistance to therapy

5. Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential therapeutic targets in myeloid cell therapy for overcoming chemoresistance and immune suppression in gastrointestinal tumors;Critical Reviews in Oncology/Hematology;2024-06

2. Downregulation of T-cell cytotoxic marker IL18R1 promotes cancer proliferation and migration and is associated with dismal prognosis and immunity in lung squamous cell carcinoma;Frontiers in Immunology;2022-12-05

3. SOX2 function in cancers: Association with growth, invasion, stemness and therapy response;Biomedicine & Pharmacotherapy;2022-12

4. Oncofetal proteins and cancer stem cells;Essays in Biochemistry;2022-09

5. LncRNA KASRT Serves as a Potential Treatment Target by Regulating SRSF1-Related KLF6 Alternative Splicing and the P21/CCND1 Pathway in Osteosarcoma: An In Vitro and In Vivo Study;Frontiers in Oncology;2021-09-09